antigen
releas
vsvinfect
dna
transfect
cell
vlp
e
alon
alon
better
character
relev
immunogen
western
blot
andor
elisa
use
zikv
specif
reagent
use
character
supernat
although
method
section
indic
western
blot
analysi
perform
cell
supernat
western
blot
present
figur
includ
cell
lysat
particularli
relev
e
vaccin
candid
prior
studi
flavivirus
indic
critic
role
prm
proper
fold
releas
e
protein
mammalian
cell
shown
tbev
allison
et
al
pmid
thu
perhap
surpris
zikv
e
construct
effect
immunogen
could
improperli
fold
releas
cell
inclus
e
vaccin
candid
could
potenti
remov
altogeth
sequenc
construct
need
detail
method
particularli
amino
acid
start
end
prm
e
inform
leader
sequenc
use
prior
prm
e
surpris
prme
dna
vaccin
studi
result
poor
immun
respons
seemingli
ident
vaccin
elicit
robust
bind
neutral
antibodi
respons
week
postvaccin
singl
dose
also
balbc
mice
dowd
et
al
pmid
supplementari
materi
discrep
address
amino
acid
sequenc
clarifi
manuscript
inclus
prme
subvir
particl
vaccin
relev
field
recent
studi
indic
antibodi
partial
protect
flaviviru
infect
howev
vaccin
construct
need
describ
character
greater
detail
prior
make
comparison
draw
conclus
regard
immunogen
major
figur
need
clarif
number
repeat
perform
statist
shown
ie
median
versu
mean
error
bar
includ
clearli
denot
figur
legend
experi
differ
growth
kinet
etc
conclud
confirm
multipl
independ
experi
exampl
attenu
figur
author
includ
follow
citat
discuss
protect
effect
antibodi
beatti
et
al
pmid
line
attenu
growth
figur
statist
support
line
weight
loss
occur
look
slight
dip
also
seen
figur
manuscript
entitl
novel
zika
viru
vaccin
express
premembran
envelop
protein
author
investig
viabil
vesicular
stomat
viru
vsv
express
zikav
full
length
envelop
protein
truncat
protein
isol
togeth
prm
protein
vaccin
strategi
zika
immun
respons
protect
induc
virus
analyz
mice
manuscript
well
written
result
consist
howev
point
could
improv
qualiti
manuscript
list
introduct
pg
author
use
term
congenit
zika
syndrom
prefer
adopt
descript
effect
zika
infect
fetu
infant
pg
author
cite
anoth
paper
also
test
vsv
express
prme
zikav
mice
discuss
articl
detail
discuss
section
present
differ
present
manuscript
result
pg
present
zika
envelop
protein
structur
poor
author
explain
compos
ectodomain
consist
three
domain
ii
iii
stem
transmembran
region
could
cite
refer
sirohi
et
al
scienc
investig
structur
viru
explan
could
perhap
insert
introduct
section
result
materi
method
author
could
indic
part
delet
truncat
e
protein
remov
stem
transmembran
region
fig
one
band
correspond
protein
also
present
infect
cell
pg
last
sentenc
author
affirm
result
demonstr
inocul
induc
high
antibodi
level
week
inocul
observ
fig
see
fig
antibodi
level
group
similar
detect
mice
immun
truncat
e
protein
without
prm
pg
author
affirm
result
demonstr
coexpress
enhanc
respons
also
comment
group
ifng
also
higher
compar
group
fig
suggest
respons
seem
presenc
lead
balanc
respons
includ
cell
author
affirm
mtdvsvbase
vaccin
safe
saw
fig
anim
immun
also
lost
bodi
weight
overal
cautiou
assert
safeti
virus
base
present
studi
pg
author
immun
anim
intramuscular
rout
balbc
mice
inocul
intranas
suscept
intranas
rout
would
lead
high
morbid
death
standard
deviat
insert
sever
graph
fig
inform
figur
legend
discuss
pg
author
compar
two
immun
rout
intramuscular
intranas
suggest
may
play
role
antibodi
respons
delay
instanc
howev
case
inocul
rout
could
influenc
result
also
background
anim
balbc
pg
author
compar
immun
respons
induc
dna
vsvbase
vaccin
also
interest
evalu
longterm
respons
induc
strategi
review
novel
zika
viru
vaccin
express
premembran
envelop
protein
manuscript
describ
gener
character
vsv
base
zika
vaccin
anzhong
li
etal
convincingli
demonstr
protect
zika
challeng
use
mtase
defect
less
pathogen
wildtyp
viru
howev
weak
first
way
mani
figur
restrict
maximum
lot
result
consolid
result
remov
exampl
partial
protect
statement
convinc
base
mous
major
comment
concern
line
base
current
publish
data
neutral
antibodi
zika
envelop
essenti
viral
clearanc
importantli
zika
vaccin
without
envelop
protein
contain
antigen
shown
protect
zika
challeng
manuscript
sentenc
need
remov
abstract
line
intranas
rout
immun
ideal
translat
human
author
intramuscular
immun
line
zika
viru
control
would
requir
order
conclus
draw
similar
vlp
made
rvsvzika
construct
zika
viru
em
low
qualiti
conclus
support
present
data
remov
figur
vlp
statement
manuscript
line
author
conduct
pathogen
experi
intranas
inocul
recombin
vsvzika
vaccin
use
weight
loss
measur
pathogen
look
figur
mice
except
pciprm
dmem
control
show
vari
degre
weight
loss
indic
construct
show
pathogen
earlier
time
point
order
conclus
prove
recombin
vaccin
truli
nonpathogen
mous
brain
harvest
endpoint
analyz
viral
vsv
rna
figur
b
c
import
control
rvsvprme
rvsv
figur
ideal
attenu
rvsv
express
less
zika
e
comparison
rvsvprme
line
dose
rout
zika
challeng
mention
result
legend
method
section
reader
go
result
figur
legend
method
get
complet
inform
line
import
show
complet
clearanc
zika
viru
day
futur
time
point
vaccin
group
unvaccin
group
data
shown
zika
viral
rna
data
differ
group
differ
day
could
consolid
one
graph
replac
figur
b
figur
consolid
graph
ie
week
zika
e
igg
respons
also
mention
legend
titer
shown
total
igg
titer
figur
consolid
graph
figur
f
also
consolid
graph
line
strain
rout
zika
viru
challeng
mention
reader
go
result
figur
legend
method
get
complet
inform
confus
line
experi
termin
day
point
mice
immun
viremia
brain
lung
spleen
uteru
symptom
enceph
henc
difficult
conclud
partial
protect
base
slightli
reduc
symptom
symptom
bia
criteria
first
place
construct
use
studi
author
suddenli
switch
dna
vaccin
platform
studi
data
need
remov
topic
addit
author
could
includ
vsv
viral
load
brain
mice
immun
mtase
defectivervsvzika
vaccin
challeng
zika
viru
supplement
figur
rule
pathogen
viral
vector
immunocompromis
mice
line
provid
partial
protect
conclud
cell
respons
seen
construct
dna
vaccin
line
rout
zikv
challeng
mention
method
section
minor
comment
line
relabel
figur
nt
exist
introduct
thank
three
review
care
review
manuscript
identifi
number
construct
thought
comment
extrem
help
revis
manuscript
modifi
manuscript
accord
comment
point
address
two
major
comment
antigen
releas
vsvinfect
dna
transfect
cell
vlp
e
alon
alon
better
character
relev
immunogen
western
blot
andor
elisa
use
zikv
specif
reagent
use
character
supernat
although
method
section
indic
western
blot
analysi
perform
cell
supernat
western
blot
present
figur
includ
cell
lysat
particularli
relev
e
vaccin
candid
prior
studi
flavivirus
indic
critic
role
prm
proper
fold
releas
e
protein
mammalian
cell
shown
tbev
allison
et
al
pmid
thu
perhap
surpris
zikv
e
construct
effect
immunogen
could
improperli
fold
releas
cell
inclus
e
vaccin
candid
could
potenti
remov
altogeth
respons
thank
comment
provid
western
blot
data
character
zikv
antigen
releas
cell
cultur
supernat
pleas
see
e
pleas
see
line
line
recombin
vsv
coexpress
prm
ee
truncat
releas
high
level
ee
truncat
supernat
even
without
need
concentr
supernat
suggest
ee
truncat
highli
express
vsv
vector
secret
cell
cultur
medium
contrast
ee
truncat
undetect
supernat
express
without
prm
consist
previou
observ
prm
play
critic
role
proper
fold
releas
e
protein
tbev
allison
et
al
pmid
paper
cite
manuscript
use
rvsve
alon
control
show
e
alon
effect
vaccin
candid
test
mice
sequenc
construct
need
detail
method
particularli
amino
acid
start
end
prm
e
inform
leader
sequenc
use
prior
prm
e
surpris
prme
dna
vaccin
studi
result
poor
immun
respons
seemingli
ident
vaccin
elicit
robust
bind
neutral
antibodi
respons
week
postvaccin
singl
dose
also
balbc
mice
dowd
et
al
pmid
supplementari
materi
discrep
address
amino
acid
sequenc
clarifi
manuscript
inclus
prme
subvir
particl
vaccin
relev
field
recent
studi
indic
antibodi
partial
protect
flaviviru
infect
howev
vaccin
construct
need
describ
character
greater
detail
prior
make
comparison
draw
conclus
regard
immunogen
provid
detail
inform
sequenc
construct
materi
method
pleas
see
line
studi
use
pci
vector
construct
dna
vaccin
pciprm
use
control
show
express
e
protein
rvsvprme
infect
cell
significantli
higher
pciprm
transfect
cell
mice
vaccin
studi
show
singl
dose
vaccin
recombin
rvsvprme
trigger
significantli
higher
zikv
antibodi
respons
pciprm
despit
fact
mice
pciprm
group
boost
data
suggest
rvsvbase
zikv
vaccin
higher
immunogen
dna
vaccin
studi
found
antibodi
induc
earli
time
point
week
postvaccin
zikv
dna
vaccin
low
howev
late
time
point
week
found
dna
vaccin
capabl
trigger
high
antibodi
consist
previou
studi
efficaci
dna
vaccin
may
affect
mani
factor
plasmid
vector
adjuv
deliveri
strategi
previous
two
public
show
zika
dna
vaccin
encod
prme
effect
trigger
zikvspecif
immun
respons
provid
suffici
protect
zikv
challeng
larocca
et
al
show
high
titer
zikv
especif
elisa
antibodi
detect
week
balbc
mice
immun
intramuscularli
dna
vaccin
howev
antibodi
titer
earli
time
point
week
report
studi
dowd
et
al
show
high
titer
zikv
antibodi
detect
week
mice
dna
vaccin
deliv
electropor
addit
antibodi
trigger
dna
vaccin
higher
balbc
mice
discuss
articl
revis
manuscript
pleas
see
line
thank
review
comment
role
modul
flaviviru
immun
respons
show
zikv
modul
zikvspecif
antibodi
cell
immun
respons
provid
evid
alon
provid
partial
protect
zikv
infect
mice
suggest
review
construct
show
provid
substanti
protect
zikvinduc
viremia
pleas
see
respons
review
detail
previous
protein
sever
flavivirus
dengu
viru
west
nile
viru
yellow
fever
viru
provid
partial
complet
protect
viru
challeng
result
consist
previou
observ
protein
flavivirus
respons
ye
use
arrow
indic
zikv
vlp
vsv
suggest
review
also
purifi
zikv
virion
perform
em
analysi
em
imag
nativ
zikv
virion
shown
comparison
zikv
vlp
pleas
see
line
figur
plaqu
help
size
descript
text
provid
enough
context
agre
review
report
imag
viral
plaqu
supplementari
figur
figur
statist
support
line
weight
loss
occur
look
slight
dip
also
seen
figur
modifi
sentenc
reflect
data
figur
femal
mice
per
group
use
studi
statist
analysi
show
signific
differ
among
dmem
p
fig
mice
femal
male
per
group
use
studi
bodi
weight
signific
differ
dmem
group
p
howev
signific
less
bodi
weight
gain
day
compar
dmem
control
group
p
mice
group
bodi
weight
loss
group
probabl
femal
male
mice
use
experi
wherea
femal
mice
use
experi
mice
signific
weight
loss
p
wherea
still
experienc
signific
weight
loss
day
p
combin
data
show
much
attenu
modifi
descript
weight
chang
experi
pleas
see
line
line
line
figur
group
mislabel
respons
correct
figur
viremia
data
shown
group
control
group
respons
ye
provid
viremia
data
group
day
postchalleng
pleas
see
line
experi
first
determin
dynam
viremia
unvaccin
challeng
control
group
zikv
challeng
shown
peak
viremia
occur
day
postchalleng
start
drop
day
day
viremia
drop
background
level
unvaccin
challeng
control
group
also
consist
previou
observ
zikv
infect
caus
transit
viremia
immunocompet
mice
complet
detect
viremia
day
postchalleng
viremia
vaccin
group
pciprm
clear
wherea
zikv
rna
still
detect
unvaccin
control
group
therefor
necessari
detect
viremia
day
postchalleng
introduct
pg
author
use
term
congenit
zika
syndrom
prefer
adopt
descript
effect
zika
infect
fetu
infant
respons
ye
correct
pg
author
cite
anoth
paper
also
test
vsv
express
prme
zikav
mice
discuss
articl
detail
discuss
section
present
differ
present
manuscript
provid
detail
discuss
paper
pleas
see
line
pg
present
zika
envelop
protein
structur
poor
author
explain
compos
ectodomain
consist
three
domain
ii
iii
stem
transmembran
region
could
cite
refer
sirohi
et
al
scienc
investig
structur
viru
explan
could
perhap
insert
introduct
section
result
materi
method
author
could
indic
part
delet
truncat
e
protein
remov
stem
transmembran
region
modifi
descript
zika
envelop
structur
cite
paper
suggest
review
includ
materi
method
section
ye
remov
stem
transmembran
region
construct
e
truncat
mutant
pleas
see
line
fig
one
band
correspond
protein
also
present
infect
cell
respons
theoret
abl
detect
protein
cell
use
metabol
label
experi
vsv
n
protein
zikv
protein
similar
molecular
weight
abl
separ
sdspage
experi
therefor
perform
western
blot
analysi
use
antibodi
shown
e
protein
detect
western
blot
confirm
express
cleav
polypeptid
review
correct
mice
group
similar
level
antibodi
mice
immun
truncat
e
protein
without
prm
sentenc
modifi
pg
author
affirm
result
demonstr
coexpress
enhanc
respons
also
comment
group
ifng
also
higher
compar
group
fig
suggest
respons
seem
presenc
lead
balanc
respons
includ
cell
review
correct
coexpress
higher
respons
group
presenc
lead
balanc
respons
includ
cell
ad
point
result
section
pleas
see
line
author
affirm
mtdvsvbase
vaccin
safe
saw
fig
anim
immun
also
lost
bodi
weight
overal
cautiou
assert
safeti
virus
base
present
studi
thank
review
question
pleas
see
respons
review
weight
loss
experi
studi
show
mrna
cap
methyl
serv
approach
attenu
vsv
util
vaccin
vector
current
studi
use
mutat
vsv
l
protein
defect
methyl
achiev
attenu
use
mutat
mtase
activ
site
detect
methyl
previou
public
show
recombin
virus
complet
attenu
balbc
mice
et
al
journal
virolog
ad
discuss
section
pleas
see
line
pg
author
immun
anim
intramuscular
rout
balbc
mice
inocul
intranas
suscept
intranas
rout
would
lead
high
morbid
death
respons
thank
review
comment
ye
mice
much
suscept
vsv
infect
balbc
mice
dose
pfu
vsv
lethal
mice
intranas
inocul
vsv
infect
olfactori
neuron
nasal
mucosa
subsequ
enter
central
nervou
system
cn
olfactori
nerv
dissemin
brain
thu
design
experi
mice
chose
intramuscular
rout
vaccin
reduc
side
effect
addit
known
intramuscular
rout
effect
deliveri
vsv
mice
importantli
result
show
pfu
higher
lethal
dose
complet
attenu
mice
wherea
still
caus
weight
loss
result
demonstr
highli
attenu
mice
standard
deviat
insert
sever
graph
fig
inform
figur
legend
ad
standard
deviat
figur
pg
author
compar
two
immun
rout
intramuscular
intranas
suggest
may
play
role
antibodi
respons
delay
instanc
howev
case
inocul
rout
could
influenc
result
also
background
anim
balbc
review
correct
possibl
background
mice
may
affect
immun
respons
modifi
sentenc
pg
author
compar
immun
respons
induc
dna
vsvbase
vaccin
also
interest
evalu
longterm
respons
induc
strategi
respons
result
show
vsvbase
vaccin
candid
higher
immunogen
compar
dna
vaccin
base
shortterm
immun
experi
futur
compar
longterm
immun
respons
dna
vsvbase
vaccin
review
weak
first
way
mani
figur
restrict
maximum
lot
result
consolid
result
remov
exampl
partial
protect
statement
convinc
base
consolid
result
figur
result
report
supplementari
figur
total
find
alon
provid
partial
protect
could
interest
zikv
flaviviru
field
suggest
review
gener
express
alon
compar
protect
efficaci
balbc
mice
found
provid
substanti
protect
viremia
balbc
mice
result
shown
h
line
combin
previou
data
mice
reason
conclud
alon
provid
partial
protect
zikv
infect
fact
data
consist
previou
observ
sever
flavivirus
major
comment
concern
line
base
current
publish
data
neutral
antibodi
zika
envelop
essenti
viral
clearanc
importantli
zika
vaccin
without
envelop
protein
contain
antigen
shown
protect
zika
challeng
manuscript
sentenc
need
remov
abstract
respons
agre
review
statement
neutral
antibodi
zika
envelop
essenti
viral
clearanc
howev
addit
experi
mice
new
data
found
provid
substanti
protect
viremia
balbc
mice
data
also
show
coexpress
prme
modul
cell
antibodi
respons
taken
togeth
play
import
role
modul
zikv
immun
respons
modifi
line
line
intranas
rout
immun
ideal
translat
human
author
intramuscular
immun
respons
review
correct
intranas
rout
immun
may
translat
human
howev
shown
vsvbase
vaccin
deliv
anim
via
mani
rout
intranas
intramuscular
oral
etc
fact
show
intramuscular
vaccin
vsvbase
vaccin
also
trigger
high
level
protect
immun
suggest
intramuscular
vaccin
effect
trigger
immun
respons
pleas
also
see
respons
review
vaccin
rout
line
zika
viru
control
would
requir
order
conclus
draw
similar
vlp
made
rvsvzika
construct
zika
viru
em
low
qualiti
conclus
support
present
data
remov
figur
vlp
statement
manuscript
respons
ye
includ
em
imag
purifi
zika
viru
virion
control
also
provid
zikv
vlp
imag
higher
magnif
list
supplementari
figur
critic
demonstr
express
zikv
prme
antigen
vsv
lead
assembl
zikv
vlp
contain
optim
epitop
trigger
immun
respons
em
analysi
show
express
prme
led
high
yield
zikv
vlp
label
vsv
zikv
vlp
imag
also
modifi
vlp
statement
manuscript
suggest
review
pleas
see
line
line
author
conduct
pathogen
experi
intranas
inocul
recombin
vsvzika
vaccin
use
weight
loss
measur
pathogen
look
figur
mice
except
pciprm
dmem
control
show
vari
degre
weight
loss
indic
construct
show
pathogen
earlier
time
point
order
conclus
prove
recombin
vaccin
truli
nonpathogen
mous
brain
harvest
endpoint
analyz
viral
vsv
rna
analyz
infecti
vsv
brain
tissu
plaqu
assay
vsv
rna
realtim
rtpcr
anim
experi
result
report
respons
agre
review
provid
viremia
data
day
postchalleng
pleas
see
line
shown
zika
viru
complet
clear
vaccin
group
wherea
unvaccin
challeng
control
still
detect
viremia
pleas
also
see
respons
review
figur
consolid
graph
ie
week
zika
e
igg
respons
also
mention
legend
titer
shown
total
igg
titer
figur
consolid
graph
figur
f
also
consolid
graph
thank
review
suggest
sinc
panel
contain
number
group
need
statist
label
figur
becom
complic
combin
panel
clariti
chose
keep
separ
panel
singl
figur
also
indic
legend
titer
shown
total
igg
titer
line
strain
rout
zika
viru
challeng
mention
reader
go
result
figur
legend
method
get
complet
inform
confus
clearli
indic
strain
rout
zika
viru
use
challeng
line
experi
termin
day
point
mice
immun
viremia
brain
lung
spleen
uteru
symptom
enceph
henc
difficult
conclud
partial
protect
base
slightli
reduc
symptom
symptom
bia
criteria
first
place
construct
use
studi
author
suddenli
switch
dna
vaccin
platform
studi
data
need
remov
topic
suggest
review
construct
compar
protect
efficaci
balbc
mice
new
result
report
h
main
find
trigger
significantli
higher
antibodi
provid
substanti
protect
viremia
compar
pci
control
group
higher
protect
efficaci
day
postzikv
challeng
viremia
clear
mice
vaccin
wherea
signific
viremia
still
detect
group
pleas
see
line
also
attempt
test
mice
unfortun
still
caus
signific
bodi
weight
loss
mice
therefor
termin
studi
discuss
section
discuss
strategi
attenu
order
test
mice
pleas
see
line
origin
submiss
result
indic
capabl
provid
partial
protect
zikv
challeng
mice
base
fact
show
less
bodi
weight
loss
zikv
associ
symptom
enceph
compar
pci
control
b
c
group
statist
less
viremia
brain
lung
spleen
uteru
compar
pci
control
note
use
high
dose
pfu
zikv
challeng
experi
mice
publish
literatur
sever
zikv
research
use
pfu
zikv
challeng
experi
mice
lazear
et
al
aliota
et
al
sinc
highli
suscept
zikv
infect
level
immun
respons
induc
may
strong
enough
confer
complet
protect
high
dose
zikv
challeng
futur
experi
compar
abil
alon
deliv
vsv
vector
dna
vaccin
protect
differ
dose
zikv
challeng
mice
final
partial
even
complet
protect
induc
alon
report
sever
flavivirus
west
nile
viru
dengu
viru
yellow
fever
viru
taken
togeth
data
balbc
mice
support
conclus
protein
zikv
play
import
role
protect
zikv
infect
find
interest
field
zikv
flaviviru
therefor
decid
keep
data
current
manuscript
addit
author
could
includ
vsv
viral
load
brain
mice
immun
mtase
defectivervsvzika
vaccin
challeng
zika
viru
supplement
figur
rule
pathogen
viral
vector
immunocompromis
mice
includ
data
vsv
viral
load
brain
mice
pleas
see
line
first
infecti
vsv
detect
mice
vaccin
second
vsv
rna
undetect
group
realtim
rtpcr
wherea
approxim
log
vsv
rna
detect
data
consist
data
bodi
weight
chang
recombin
caus
bodi
weight
loss
mice
wherea
still
caus
weight
loss
earli
time
point
data
demonstr
significantli
attenu
line
provid
partial
protect
conclud
cell
respons
seen
construct
dna
vaccin
modifi
sentenc
describ
provid
new
data
show
provid
substanti
protect
viremia
balbc
mice
line
rout
zikv
challeng
mention
method
section
author
perform
addit
studi
particularli
newli
gener
construct
address
mani
review
concern
howev
rais
signific
issu
construct
use
studi
author
includ
leader
sequenc
prior
start
prm
rvsv
construct
includ
prm
protein
eonli
construct
also
preced
leader
sequenc
yet
lack
leader
sequenc
like
explain
full
length
e
construct
detect
even
cell
lysat
infect
cell
fig
direct
correct
cellular
compart
use
rvsve
neg
control
odd
choic
full
length
membran
bound
e
protein
would
predict
use
immunogen
regardless
even
proper
leader
sequenc
would
secret
construct
issu
cytoplasm
protein
direct
er
lumen
polyprotein
translat
except
prmcontain
construct
protect
effect
construct
nonprotect
ealon
construct
use
current
studi
base
express
viral
protein
manner
occur
viru
replic
descript
zikv
sequenc
use
gener
pci
plasmid
construct
assum
also
lack
leader
sequenc
addit
mani
statement
support
data
line
overal
rvsv
coexpress
prm
ee
truncat
mutant
attenu
mice
rvsv
express
ee
truncat
alon
statement
support
data
figur
line
contrast
mice
vaccin
pciprm
protect
fig
somewhat
true
ye
level
protect
vaccin
group
detect
viremia
least
anim
line
similarli
high
level
zikv
detect
brain
uteru
lung
spleen
pci
control
group
wherea
zikv
rna
detect
organ
group
fig
truether
detect
viremia
limit
detect
graph
line
day
postchalleng
viremia
detect
wherea
signific
viremia
present
pci
truether
detect
viremia
figur
use
word
signific
question
group
viremia
close
limit
detect
line
fact
greater
protect
efficaci
viremia
day
postchalleng
mice
fig
ignor
fact
differ
rather
small
longer
observ
day
group
detect
viremia
addit
comment
paragraph
start
line
descript
viru
subvir
particl
structur
well
associ
prm
e
lack
prm
protein
integr
part
virion
subvir
particl
undergo
cleavag
event
viru
matur
text
read
prm
exist
allow
proper
fold
e
addit
subvir
particl
form
vivo
yet
text
suggest
recombinantli
express
line
express
prm
follow
truncat
e
result
secret
solubl
e
expect
immunogen
subvir
particl
versu
solubl
e
acknowledg
clearli
throughout
manuscript
particularli
evid
lack
western
blot
analysi
prm
visibl
cell
lysat
supernat
prme
construct
figur
still
lack
clariti
data
repres
method
state
experi
done
three
time
broad
statement
appli
variou
type
experi
present
within
individu
experi
replic
multipl
review
comment
lack
descript
regard
error
bar
author
repli
amend
manuscript
none
figur
legend
state
error
bar
denot
standard
deviat
standard
error
confid
interv
mani
figur
state
whether
statist
indic
mean
median
figur
exampl
em
pictur
includ
zikv
virion
descript
anywher
sampl
viru
strain
cell
produc
figur
mous
sampl
pool
treat
individu
cell
experi
know
make
imposs
determin
data
express
graph
group
averag
calcul
individu
mice
repeat
three
time
method
state
reflect
graph
limit
detect
qrtpcr
graph
consist
compar
figur
figur
experi
zikv
figur
versu
vsv
qrtpcrall
differ
limit
detect
line
limit
detect
also
seem
high
log
zikv
result
often
graph
limit
detect
exact
valu
detect
level
constant
limit
detect
use
line
singlestep
replic
curv
show
replic
kinet
similar
wherea
signific
delay
fig
statist
use
compar
pvalu
line
mice
group
exhibit
clinic
sign
less
sever
pci
group
fig
statist
one
mice
clinic
score
absolut
valu
pvalu
provid
author
review
question
point
review
howev
question
concern
safeti
vaccin
bodi
weight
loss
anim
inocul
recombin
vsv
fulli
elucid
differ
observ
fig
satisfactorili
clarifi
discuss
novel
zika
viru
vaccin
express
premembran
envelop
protein
review
highli
appreci
author
effort
satisfi
comment
howev
follow
comment
consid
major
concern
figur
state
author
zikv
vlp
express
vsv
virus
smaller
nativ
zikv
virion
unclear
author
claim
structur
similar
zikv
virion
consid
zikv
virion
granular
exactli
spheric
zikv
vlp
made
vsv
opaqu
spheric
structur
author
remov
sentenc
size
bar
one
panel
figur
poor
qualiti
nt
add
lot
introduct
thank
three
review
care
review
manuscript
construct
thought
comment
extrem
help
improv
manuscript
took
us
approxim
three
month
complet
new
experi
review
suggest
make
new
recombin
vsv
anchor
c
leader
sequenc
signal
peptid
construct
test
mice
review
request
monitor
viremia
prolong
time
day
zikv
challeng
complet
experi
modifi
manuscript
address
point
describ
major
comment
eonli
construct
also
preced
leader
sequenc
yet
lack
leader
sequenc
like
explain
full
length
e
construct
detect
even
cell
lysat
infect
cell
direct
correct
cellular
compart
review
rais
good
point
construct
recombin
vsv
express
e
leader
sequenc
anchor
c
signal
peptid
recombin
virus
name
rvsvae
distinguish
origin
virus
construct
diagram
plaqu
size
shown
also
compar
express
e
protein
recombin
virus
without
anchor
c
sequenc
anchor
c
sequenc
express
ee
truncat
protein
cell
lysat
significantli
increas
compar
without
anchor
c
sequenc
addit
e
truncat
secret
cell
cultur
medium
wherea
fulllength
e
protein
new
result
report
pleas
see
respons
comment
construct
use
rvsve
neg
control
odd
choic
full
length
membran
bound
e
protein
would
predict
use
immunogen
regardless
even
proper
leader
sequenc
would
secret
address
concern
construct
anoth
recombin
viru
express
e
anchor
c
sequenc
recombin
viru
name
subsequ
perform
new
anim
studi
test
immunogen
mice
compar
result
report
e
f
pleas
see
line
mice
group
especif
antibodi
respons
week
mice
especif
antibodi
respons
week
group
challeng
zikv
rel
lower
viremia
two
control
group
salin
statist
differ
p
similar
previou
experi
provid
protect
viremia
collect
data
demonstr
immunogen
much
lower
despit
fact
anchor
c
sequenc
includ
construct
result
also
consist
publish
literatur
show
prme
much
immunogen
e
alon
construct
issu
cytoplasm
protein
direct
er
lumen
polyprotein
translat
except
prmcontain
construct
protect
effect
construct
nonprotect
ealon
construct
use
current
studi
base
express
viral
protein
manner
occur
viru
replic
descript
zikv
sequenc
use
gener
pci
plasmid
construct
assum
also
lack
leader
sequenc
previou
version
manuscript
construct
anchor
c
sequenc
includ
construct
state
figur
legend
correct
oversight
prove
attach
upstream
primer
primer
name
vsvzikvanchor
f
bp
length
includ
anchor
c
sequenc
use
pcr
construct
pleas
see
support
materi
primer
order
sigma
left
side
revis
manuscript
brault
et
al
report
intramuscular
immun
immunocompet
mice
modifi
vaccinia
ankara
mva
vector
express
vaccin
candid
provid
protect
lethal
intracerebr
dose
zikv
strain
howev
studi
evalu
efficaci
mice
highli
sensit
zikv
infect
studi
show
provid
partial
protect
mice
brault
studi
diminish
signific
manuscript
main
emphasi
manuscript
includ
prme
zikv
vaccin
develop
result
recombin
viru
highli
attenu
balbc
mice
provid
complet
protect
zika
challeng
two
anim
model
concept
combin
novel
combin
protect
effect
e
protein
addit
mani
statement
support
data
line
overal
rvsv
coexpress
prm
ee
truncat
mutant
attenu
mice
rvsv
express
ee
truncat
alon
statement
support
data
figur
explain
weight
loss
experi
better
mice
inocul
wild
type
rvsv
kill
day
mice
inocul
recombin
vsv
zikv
gene
insert
surviv
howev
experienc
bodi
weight
loss
usual
occur
day
postinocul
group
difficult
separ
group
follow
tabl
summar
bodi
weight
day
postinocul
see
rvsv
prm
less
bodi
weight
loss
compar
rvsv
without
prm
suggest
rvsv
prm
attenu
statist
analysi
show
rvsvprme
significantli
less
bodi
weight
loss
compar
rvsve
p
significantli
less
bodi
weight
loss
compar
p
gener
consist
vsv
gene
express
strategi
larg
gene
insert
result
attenu
line
contrast
mice
vaccin
pciprm
protect
fig
somewhat
true
ye
level
protect
vaccin
group
detect
viremia
least
anim
modifi
sentenc
contrast
viremia
mice
vaccin
pciprm
group
detect
limit
day
mice
near
detect
limit
level
viremia
respect
mice
pciprm
group
high
level
viremia
addit
viremia
detect
limit
day
group
result
suggest
mice
vaccin
vaccin
candid
protect
pleas
see
line
would
fair
state
perfect
scenario
anim
studi
rare
pciprm
vaccin
group
anim
undetect
viremia
detect
limit
wherea
low
level
viremia
near
detect
limit
level
variabl
normal
realtim
rtpcr
highli
sensit
method
particularli
ct
valu
reach
detect
limit
given
fact
singl
dose
vaccin
efficaci
would
consid
high
review
suggest
monitor
viremia
prolong
time
experi
anim
experi
actual
monitor
viremia
day
zikv
challeng
except
pciprm
group
monitor
day
show
viremia
level
day
time
show
viremia
data
day
dot
format
indic
mani
anim
detect
limit
previou
version
manuscript
viremia
data
balbc
mice
shown
rna
copiesml
wherea
viremia
data
mice
shown
log
pfu
equival
rnaml
consist
use
log
pfu
equival
rnaml
viremia
data
pleas
also
see
respons
regard
detect
limit
blood
differ
tissu
note
repeat
anim
experi
see
anim
experi
revis
result
report
e
f
pleas
see
line
result
essenti
similar
line
similarli
high
level
zikv
detect
brain
uteru
lung
spleen
pci
control
group
wherea
zikv
rna
detect
organ
group
fig
truether
detect
viremia
limit
detect
graph
modifi
sentenc
similarli
high
level
zikv
detect
brain
uteru
lung
spleen
pci
control
group
wherea
near
detect
limit
level
zikv
rna
found
organ
group
variabl
normal
ct
valu
near
detect
limit
also
consist
sever
zikv
vaccin
studi
exampl
mrna
vaccin
studi
publish
richner
et
al
cell
panel
g
h
j
pleas
also
see
respons
comment
perfect
anim
studi
rare
line
day
postchalleng
viremia
detect
wherea
signific
viremia
present
pci
truether
detect
viremia
figur
use
word
signific
question
group
viremia
close
limit
detect
modifi
sentenc
day
postchalleng
mice
group
detect
viremia
except
one
group
near
detect
limit
wherea
mice
pci
group
still
signific
level
viremia
p
see
line
line
fact
greater
protect
efficaci
viremia
day
postchalleng
mice
fig
ignor
fact
differ
rather
small
longer
observ
day
group
detect
viremia
respons
day
differ
small
viremia
statist
lower
p
true
group
low
level
viremia
day
dramat
differ
vaccin
pci
control
group
see
b
request
review
editor
longterm
studi
monitor
mous
bodi
weight
viremia
day
mice
zikv
challeng
bodi
weight
loss
viremia
observ
day
time
period
except
near
detect
limit
level
viremia
day
pleas
also
see
respons
review
paragraph
start
line
descript
viru
subvir
particl
structur
well
associ
prm
e
lack
prm
protein
integr
part
virion
subvir
particl
undergo
cleavag
event
viru
matur
text
read
prm
exist
allow
proper
fold
e
addit
subvir
particl
form
vivo
yet
text
suggest
recombinantli
express
line
express
prm
follow
truncat
e
result
secret
solubl
e
expect
immunogen
subvir
particl
versu
solubl
e
acknowledg
clearli
throughout
manuscript
particularli
evid
lack
western
blot
analysi
prm
visibl
cell
lysat
supernat
prme
construct
modifi
sentenc
descript
prm
ad
tri
perform
western
blot
use
antibodi
prm
unfortun
antibodi
work
assay
howev
western
blot
e
andor
antibodi
clearli
demonstr
prme
cleav
figur
still
lack
clariti
data
repres
method
state
experi
done
three
time
broad
statement
appli
variou
type
experi
present
within
individu
experi
replic
multipl
review
comment
lack
descript
regard
error
bar
author
repli
amend
manuscript
none
figur
legend
state
error
bar
denot
standard
deviat
standard
error
confid
interv
mani
figur
state
whether
statist
indic
mean
median
figur
exampl
respons
thank
strictli
follow
standard
requir
biolog
experi
figur
legend
clearli
state
number
replic
experi
data
present
gener
two
type
experi
manuscript
first
vitro
experi
western
blot
viru
growth
curv
done
three
independ
experi
western
blot
gel
present
repres
three
independ
experi
viru
growth
data
perform
three
independ
experi
express
geometr
mean
titer
gmt
standard
deviat
state
second
vivo
anim
experi
anim
experi
mice
usedgroup
attain
power
statist
analysi
data
bodi
weight
cell
respons
mean
mice
express
mean
standard
deviat
antibodi
titer
viral
rna
titer
geometr
mean
titer
gmt
mice
standard
deviat
respons
explain
experi
better
cell
assay
mous
sampl
treat
individu
euthanasia
spleen
isol
mous
homogen
cell
suspens
prepar
split
three
well
triplic
per
mous
microtit
plate
precoat
zikv
e
protein
cultur
day
flow
cytometri
perform
intracellular
stain
correspond
anticytokin
group
data
express
mean
posit
cell
mean
sampl
well
mice
standard
deviat
clearli
state
figur
legend
limit
detect
qrtpcr
graph
consist
compar
figur
figur
experi
zikv
figur
versu
vsv
qrtpcrall
differ
limit
detect
line
limit
detect
also
seem
high
log
zikv
result
often
graph
limit
detect
exact
valu
detect
level
constant
limit
detect
use
panel
g
h
j
rna
quantif
experi
use
sybr
greenbas
qpcr
method
takara
japan
may
rel
lower
sensit
specif
probebas
qpcr
method
also
detect
limit
anim
experi
may
slightli
differ
determin
detect
limit
experi
anim
experi
normal
control
unvaccin
unchalleng
addit
use
constant
valu
figur
valu
detect
level
previou
version
manuscript
viremia
data
balbc
mice
shown
rna
copiesml
wherea
viremia
data
mice
shown
log
pfu
equival
rnaml
consist
use
log
pfu
equival
rnaml
viremia
data
report
mani
public
fig
show
rna
copiesml
log
pfu
two
week
younger
sixweekold
femal
mice
use
fourweekold
femal
male
mice
use
younger
mice
suscept
vsv
infect
revis
conduct
new
anim
experi
anim
experi
repeat
similar
experi
three
time
experi
femal
mice
use
bodi
weight
shown
weight
loss
day
quickli
recov
bodi
weight
loss
observ
three
experi
emphas
final
signific
construct
manuscript
inocul
pfu
recombin
viru
exhibit
bodi
weight
loss
either
immunocompet
balbc
mice
fig
immunodefici
mice
demonstr
highli
attenu
safe
mice
know
pfu
wild
type
vsv
suffici
kill
mice
respons
thank
discuss
cite
two
refer
review
figur
state
author
zikv
vlp
express
vsv
virus
smaller
nativ
zikv
virion
unclear
author
claim
structur
similar
zikv
virion
consid
zikv
virion
granular
exactli
spheric
zikv
vlp
made
vsv
opaqu
spheric
structur
author
remov
sentenc
size
bar
one
panel
figur
poor
qualiti
nt
add
lot
sentenc
remov
size
bar
ad
panel
sinc
rvsvprme
produc
two
type
particl
vsv
zikv
vlp
difficult
complet
separ
zikv
vlp
vsv
vsv
genom
rna
encapsid
viral
n
protein
form
helic
ribonucleoprotein
rnp
complex
purif
difficult
elimin
rnp
complex
helic
ringlik
structur
howev
em
pictur
clearli
show
zikv
vlp
found
supernat
purpos
em
analysi
figur
unclear
author
provid
zika
viremia
immun
group
till
necropsi
reason
claim
viremia
unvaccin
group
day
satisfactori
termin
experi
immun
group
could
develop
delay
viremia
set
viral
load
increas
time
experiment
time
short
anim
observ
least
day
challeng
perform
new
anim
immun
experi
immunodefici
mice
result
report
briefli
mice
immun
pfu
salin
anim
challeng
zikv
week
postimmun
challeng
bodi
weight
viremia
monitor
day
suggest
review
editor
shown
bodi
weight
loss
observ
vaccin
demonstr
highli
attenu
mice
high
titer
especif
antibodi
detect
group
c
challeng
zikv
signific
differ
bodi
weight
chang
normal
control
group
unimmun
unchalleng
group
day
time
period
p
contrast
mice
salin
group
unimmun
challeng
group
dead
day
postchalleng
viremia
monitor
everi
day
day
viremia
detect
immun
group
day
except
near
detect
level
viremia
detect
day
challeng
data
combin
previou
data
strongli
suggest
safe
provid
complet
protect
zikv
challeng
anim
experi
origin
initi
determin
level
viremia
day
challeng
experi
actual
collect
blood
sampl
everi
day
day
challeng
except
pciprm
group
collect
day
run
realtim
rtpcr
blood
sampl
day
viremia
detect
limit
day
vaccin
group
therefor
merg
origin
b
c
one
panel
describ
viremia
day
group
except
pciprm
day
time
also
show
viremia
data
day
dot
format
indic
mani
anim
detect
limit
pleas
see
respons
review
addit
comment
review
remark
author
author
gener
new
vaccin
construct
perform
addit
anim
experi
greatli
strengthen
paper
importantli
ensur
construct
express
zikv
e
e
truncat
encod
leader
sequenc
appropri
beg
question
data
obtain
origin
construct
lack
leader
sequenc
still
includ
particularli
western
blot
paper
somewhat
lengthi
would
suggest
remov
result
much
data
present
construct
design
express
solubl
e
could
also
remov
never
test
mous
challeng
model
add
much
paper
believ
manuscript
could
shorten
focus
construct
encod
overal
author
appropri
respond
review
comment
author
work
hard
answer
question
point
refere
perform
sever
experi
includ
construct
recombin
vsv
encod
full
length
e
gene
well
truncat
sequenc
gene
fuse
signal
peptid
sequenc
correspond
ctermin
region
c
protein
show
rvsv
construct
anchor
c
signal
peptid
led
abund
express
ee
truncat
compart
construct
without
peptid
sequenc
import
e
truncat
protein
secret
extracellular
medium
howev
experi
perform
order
evalu
immunogen
rvsv
e
truncat
construct
protect
potenti
understand
manuscript
alreadi
extens
result
indic
construct
seem
induc
better
respons
compar
other
inform
e
truncat
secret
extracellular
medium
miss
possibl
secret
e
protein
without
ctermin
sequenc
highli
hydrophob
context
without
prm
induc
neutral
antibodi
could
protect
would
good
author
includ
one
tabl
summar
construct
either
rvsv
dna
vaccin
antibodi
respons
protect
organ
inform
present
manuscript
describ
separ
differ
figur
pg
line
author
seem
surpris
secret
howev
expect
sinc
natur
signal
peptid
present
ctermin
sequenc
e
protein
includ
construct
comment
legend
fig
author
could
includ
criteria
use
consid
differ
score
clinic
sign
